NSE - Delayed Quote INR
Alivus Life Sciences Limited (ALIVUS.NS)
1,036.30
+2.70
+(0.26%)
At close: April 25 at 3:30:02 PM GMT+5:30
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
28,504,120
27,021,470
24,710,070
19,970,750
Total Liabilities Net Minority Interest
5,180,900
5,639,400
4,166,950
12,443,280
Total Equity Gross Minority Interest
23,323,220
21,382,070
20,543,120
7,527,470
Total Capitalization
23,323,220
21,382,070
20,543,120
7,527,470
Common Stock Equity
23,323,220
21,382,070
20,543,120
7,527,470
Capital Lease Obligations
171,480
193,570
28,840
--
Net Tangible Assets
23,174,700
21,202,060
20,439,320
7,448,360
Working Capital
14,772,260
13,537,950
13,805,880
1,776,010
Invested Capital
23,323,220
21,382,070
20,543,120
7,527,470
Tangible Book Value
23,174,700
21,202,060
20,439,320
7,448,360
Total Debt
171,480
193,570
28,840
--
Share Issued
122,527.17
122,527.17
122,527.17
122,527.17
Ordinary Shares Number
122,527.17
122,527.17
122,527.17
122,527.17
3/31/2021 - 1/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade